China Pharma Holdings (CPHI) Free Cash Flow (2010 - 2026)
China Pharma Holdings (CPHI) reported Free Cash Flow of -$55292.0 for Q1 2026, up 58.11% on a YoY basis from -$34970.1 in Q1 2025, and down 136.49% quarter-over-quarter from $151536.0 in Q4 2025.
China Pharma Holdings (CPHI) Free Cash Flow (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Free Cash Flow for 17 years, with the latest figure at -$55292.0 in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 58.11% year-over-year to -$55292.0; the trailing twelve-month figure through Mar 2026 stood at $165645.0 (up 350.49% YoY), and the FY2025 full-year result was $88937.0, up 120.01% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$55292.0, down from $151536.0 in the prior quarter.
- The five-year high for Free Cash Flow was $939831.0 in Q3 2023, with the low at -$1.4 million in Q1 2023.
- Historically, Free Cash Flow has averaged -$112085.6 across 5 years, with a median of -$55292.0 in 2026.
- Annual changes were most pronounced in 2023 — Free Cash Flow surged 2911.59% — and 2025, when it sank 529.7%.
- China Pharma Holdings' Free Cash Flow stood at $611862.0 in 2022, then slumped by 104.39% to -$26850.0 in 2023, then jumped by 1139.96% to $279228.0 in 2024, then sank by 45.73% to $151536.0 in 2025, then tumbled by 136.49% to -$55292.0 in 2026.
- The last three Free Cash Flow figures came in at -$55292.0 (Q1 2026), $151536.0 (Q4 2025), and -$237598.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | -55,292.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55,292.00 |
| Mar 31, 2026 | -55,292.00 |
| Dec 31, 2025 | 151,536.00 |
| Dec 31, 2025 | 151,536.00 |
| Sep 30, 2025 | -237,598.00 |
| Sep 30, 2025 | -237,598.00 |
| Jun 30, 2025 | 306,999.00 |
| Jun 30, 2025 | 306,999.00 |
| Mar 31, 2025 | -132,000.00 |
| Mar 31, 2025 | -132,000.00 |
| Dec 31, 2024 | 279,228.00 |
| Dec 31, 2024 | 279,228.00 |
| Sep 30, 2024 | -37,732.00 |
| Sep 30, 2024 | -37,732.00 |
| Jun 30, 2024 | -72,726.00 |
| Jun 30, 2024 | -72,726.00 |
| Mar 31, 2024 | -585,158.00 |
| Mar 31, 2024 | -585,158.00 |
| Dec 31, 2023 | -26,850.00 |
| Dec 31, 2023 | -26,850.00 |